Hive Health Media

CDC Study Notes Decline in Vision Problems from Diabetes

Vision problems in diabetic patients have decreased significantly over the past 15 years, a study from the Center for Disease Control found. When the CDC conducted this study in 1997, 26% of adults suffering from diabetes reported some form of vision impairment. As of last year, that figure dropped to 18.6%. The results of the study were published in Morbidity and Mortality Weekly Report.

Changes in retina in diabetics - Diabetic Retinopathy

In their effort to establish whether or not a trend was taking place, the CDC used the same methodology in the original survey. They asked respondents whether or not a physician or other health care provider had diagnosed them with diabetes. Also, the researchers assessed whether the respondents had vision problems, regardless of whether or not they used corrective lenses.

The results of this study should be encouraging to the nearly 30 million adults suffering from diabetes and the nearly 80 million at risk of developing the disease. Diabetes is a leading cause of blindness, so many patients suffering from the disease should be relieved to hear their odds of developing vision problems have declined considerably.

The study found that the number of adults with both diabetes and vision problems increased. However, after adjusting for age, researchers found that the number of diabetes related vision problems declined considerably. The prevalence of diabetes related vision problems decreased among patients, regardless of whether or not they were treating their diabetes through insulin. Also, the number of patients with vision problems declined for patients who didn’t attempt to get corrective eye surgery.

The prevalence of diabetes related vision problems didn’t decrease among all demographic groups in the survey. Adults between the ages of 18 and 44 with diabetes were shown to have the same probability of developing vision problems as they were in the 1997 study. Also, the prevalence of vision problems stemming from diabetes didn’t decrease significantly among African-Americans and patients diagnosed with diabetes within the past three years.

The CDC is trying to explain the decrease in vision related problems stemming from diabetes. The percentage of respondents who have seen an eye-care provider has remained constant throughout the 13-year time span. The data suggests the most likely explanation for the decline is due to reductions in the cases of severe diabetic retinopathy. Diabetic retinopathy is typically exhibited in patients with Type 1 diabetes.

[box type=”important”]Although the data from this study is encouraging to adults suffering from diabetes, there were several limitations of the study. Namely, the researchers couldn’t establish the reliability of the respondents’ responses regarding their vision. Also, the study focused on the prevalence of vision problems stemming from diabetes, rather than the severity of those vision problems. Finally, the CDC was not able to evaluate members of some groups, such as members of the Armed Forces.[/box]

 

Kalen Smith is a professional Internet marketer, consumer researcher and writer. He has been a writer for Weight Loss Triumph and is the cofounder of the blog Great Paleo Diet Cookbooks, where he writes about the paleo diet and lifestyle.

2 Comments

  1. dannyhaszard1

    November 20, 2011 at 9:41 am

    Be aware of drugs that potentiate diabetes

    .Eli Lilly Zyprexa Olanzapine issues linger.

    The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease. The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays.One in 145 adults died in clinical trials of those taking the antipsychotic drug Zyprexa.

    This was Lilly’s #1 product $5 billion per year sales,moreover Lilly also make billions more on drugs that treat diabetes.

    — Daniel Haszard Zyprexa victim activist and patient.FMI zyprexa-victims(dot)com h

  2. dannyhaszard1

    November 20, 2011 at 9:41 am

    Be aware of drugs that potentiate diabetes

    .Eli Lilly Zyprexa Olanzapine issues linger.

    The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease. The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays.One in 145 adults died in clinical trials of those taking the antipsychotic drug Zyprexa.

    This was Lilly’s #1 product $5 billion per year sales,moreover Lilly also make billions more on drugs that treat diabetes.

    — Daniel Haszard Zyprexa victim activist and patient.FMI zyprexa-victims(dot)com h

Leave a Reply

Your email address will not be published. Required fields are marked *